NYSE:THC
TENET HEALTHCARE CORP
A major US-based healthcare operator offering acute hospital and ambulatory surgery services with a strong balance sheet and growing revenue stream.
Key Metrics
Investment Thesis
Bull Case
Investors may favor THC due to its consistent revenue growth trajectory from $19.17B to $21.31B over the last three years and a substantial cash balance of $2.88B providing financial flexibility. The company's large asset base of $29.68B total assets suggests strong scale, while significant share repurchases of $1.39B indicate confidence in shareholder returns despite the retained earnings deficit.
Bear Case
Concerns include the volatile net income trend with a sharp decline from $4.06B to $2.37B and high operating expenses consuming nearly 84% of gross profit. The substantial goodwill of $11.20B and negative accumulated other comprehensive income of -$181M pose balance sheet risks, while cash flow from financing outflows of -$2.40B suggest aggressive debt servicing or buyback programs that may strain liquidity.
About TENET HEALTHCARE CORP
Tenet Healthcare Corp (THC) is a leading healthcare services provider operating acute care hospitals and ambulatory surgery centers primarily across the United States. The company serves diverse markets including emergency medicine, oncology, orthopedics, and cardiac care through its extensive hospital network. Key products include comprehensive patient care services delivered via its proprietary technology platforms and specialized clinical departments.
Analysis
Management Discussion
Tenet reported strong operational performance with revenue reaching $21.31B in 2025, up from $19.17B in 2022, driven by volume growth and price adjustments. Net income fluctuated significantly, dropping to $2.37B in 2025 after a peak of $4.06B in 2024, reflecting high operating expenses of $17.80B against gross profit of $21.31B. The company maintained a healthy cash position with $2.88B in cash and equivalents while investing heavily in capital expenditures of $1.01B to support network expansion.
Industry Overview
The US healthcare services industry is characterized by high barriers to entry due to regulatory compliance and capital intensity, with Tenet competing against other large hospital operators for market share. Industry trends favor consolidation and value-based care models, which aligns with Tenet's multi-segment strategy but exposes it to reimbursement rate pressures.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $19.17B | $20.55B | $20.66B | $21.31B |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $19.17B | $20.55B | $20.66B | $21.31B |
| Operating Expenses | $16.84B | $18.04B | $14.71B | $17.80B |
| Operating Income | $2.33B | $2.51B | $5.96B | $3.51B |
| Stock-Based Comp | $56.0M | $66.0M | $67.0M | $104.0M |
| D&A | $841.0M | $870.0M | $818.0M | $863.0M |
| Depreciation | $669.0M | $696.0M | $646.0M | $697.0M |
| Amortization | $172.0M | $174.0M | $172.0M | $166.0M |
| Non-Operating Income | $-989.0M | $-893.0M | $-708.0M | $-708.0M |
| Interest Expense | $890.0M | $901.0M | — | — |
| Pre-Tax Income | $1.34B | $1.62B | $5.25B | $2.80B |
| Income Tax | $344.0M | $306.0M | $1.18B | $433.0M |
| Continuing Ops | $1.00B | $1.31B | $3.20B | $1.41B |
| Discontinued Ops | $1.0M | $0 | $864.0M | $960.0M |
| Net Income | $1.00B | $1.31B | $4.06B | $2.37B |
| Minority Interest | $590.0M | $700.0M | $864.0M | $960.0M |
| Net to Common | $411.0M | $611.0M | $3.20B | $1.41B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $5.98B | $7.17B | $7.68B | $7.85B |
| Cash & Equivalents | $858.0M | $1.23B | $3.02B | $2.88B |
| Accounts Receivable | $2.94B | $2.91B | $2.54B | $2.56B |
| Inventory | $405.0M | $411.0M | $346.0M | $348.0M |
| Other Current Assets | $1.77B | $2.61B | $1.78B | $2.05B |
| Long-Term Assets | $21.18B | $21.14B | $21.25B | $21.83B |
| Intangibles | $1.42B | $1.37B | $1.40B | $1.35B |
| Goodwill | $10.12B | $10.31B | $10.69B | $11.20B |
| Operating Leases | $1.13B | $1.08B | $1.04B | $1.13B |
| LT Securities | $30.0M | $48.0M | $50.0M | $59.0M |
| LT Investments | $1.63B | $1.56B | $1.53B | $1.44B |
| Other LT Assets | $5.24B | $5.27B | $5.07B | $5.26B |
| Total Assets | $27.16B | $28.31B | $28.94B | $29.68B |
| Current Liabilities | $4.48B | $4.76B | $4.31B | $4.46B |
| Accounts Payable | $1.50B | $1.41B | $1.29B | $1.36B |
| Current Leases | $207.0M | $204.0M | $204.0M | $214.0M |
| Deferred Revenue | $110.0M | — | $0 | — |
| Taxes Payable | — | — | $18.0M | $0 |
| Other Current Liab | $2.65B | $3.15B | $2.79B | $2.89B |
| Long-Term Liabilities | $18.07B | $18.04B | $16.08B | $16.24B |
| LT Operating Leases | $1.05B | $1.01B | $950.0M | $1.04B |
| Other LT Liab | $17.01B | $17.04B | $15.13B | $15.20B |
| Total Liabilities | $22.55B | $22.80B | $20.39B | $20.70B |
| Shareholders' Equity | $4.61B | $5.51B | $8.55B | $8.97B |
| Paid-In Capital | $4.78B | $4.83B | $4.87B | $4.91B |
| Retained Earnings | $-803.0M | $-192.0M | $3.01B | $4.42B |
| AOCI | $-181.0M | $-181.0M | $-180.0M | $-181.0M |
| Total L&E | $27.16B | $28.31B | $28.94B | $29.68B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $1.00B | $1.31B | $4.06B | $2.37B |
| Non-Cash Adjustments | $829.0M | $815.0M | $-1.72B | $950.0M |
| Working Capital Changes | $-747.0M | $248.0M | $-300.0M | $223.0M |
| Cash from Operations | $1.08B | $2.37B | $2.05B | $3.54B |
| Capital Expenditures | $762.0M | $751.0M | $931.0M | $1.01B |
| Cash from Investing | $-808.0M | $-969.0M | $3.43B | $-1.27B |
| Share Buybacks | $250.0M | $200.0M | $672.0M | $1.39B |
| Cash from Financing | $-1.78B | $-1.03B | $-3.69B | $-2.40B |
| FX Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | $-1.51B | $370.0M | $1.79B | $-136.0M |
| Beginning Cash | $2.36B | $858.0M | $1.23B | $3.02B |
| Ending Cash | $858.0M | $1.23B | $3.02B | $2.88B |
Frequently Asked Questions
How does TENET HEALTHCARE CORP make money?
Acute Care Hospitals providing inpatient and emergency services, Ambulatory Surgery Centers focusing on outpatient procedures, Home Health & Hospice delivering post-acute care, and Specialty Services including oncology and cardiac programs.
What are the main risks for THC?
Regulatory changes in healthcare reimbursement rates and policies that could impact margins, rising medical inflation affecting cost of revenue, potential liability claims from malpractice suits, and integration challenges from recent acquisitions totaling $308M.
What is THC's competitive advantage?
Extensive geographic footprint with over 100 hospitals providing market dominance in specific regions, a robust proprietary technology stack for clinical operations, and a diversified revenue stream reducing reliance on any single payer mix.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.